Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

Sermorelin.

Research draft

Sermorelin is a synthetic growth-hormone-releasing hormone fragment.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Sermorelin is a synthetic growth-hormone-releasing hormone fragment.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFO29 amino acids
PRIMARY CONTEXTGHRH (1–29) analogue

Mechanism

It stimulates pituitary growth-hormone secretion when the axis remains responsive.

Human research

Paediatric growth studies exist. These do not establish modern anti-ageing, recovery or body-composition benefits.

Preclinical & other research

Experimental GHRH research supports its endocrine action.

Safety & unknowns

Hormonal and glucose effects need clinical context; historical paediatric experience cannot establish lifelong wellness-use safety.

Regulatory status

Historical prescription-product status and current compounded availability should be assessed separately.

Reported use & evidence

Research profile draft

The supplied Sermorelin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds